NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open2,064
High2,065.4
Low2,028.5
Prev. Close2,051.1
Avg. Traded Price2,040.58
Volume18,661
MARKET DEPTH
Total bid14,221.00
Total ask16,565.00
| Orders | Qty | Bid |
|---|
| 1 | 1 | 2029.3 |
| 1 | 4 | 2029.1 |
| 3 | 19 | 2029 |
| 1 | 1 | 2028.8 |
| 1 | 1 | 2028.6 |
| Ask | Qty | Orders |
|---|
| 2030.8 | 3 | 18 |
| 2030.9 | 1 | 8 |
| 2031 | 4 | 23 |
| 2031.1 | 1 | 1 |
| 2031.5 | 3 | 7 |
HIGH/LOW
LOW/HIGH
₹2,027.0013 minutes ago
₹2,065.4043 minutes ago
Motilal Oswal Nifty Smallcap 250 Index Fund-Reg(G)
ICICI Pru Nifty Smallcap 250 Index Fund(G)
UTI Healthcare Fund-Reg(IDCW)
3Y Return+25.2%
NAV₹216.16
UTI Large & Mid Cap Fund-Reg(G)
3Y Return+24.6%
NAV₹177.59
UTI Small Cap Fund-Reg(G)
Caplin Point Laboratories was established in 1990 to manufacture a range of ointments, creams and other external applications. It is the mid-sized company in India’s pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility.
